Brain atrophy in clinically isolated syndrome;Atrofia cerebral en pacientes con śndrome desmielinizante aislado

Neurologia

Volumn 25, Issue 7, 2010, Pages 430-434

  Rojas, J I ^a   Patrucco, L ^a   Besada, C ^a   Bengolea, L ^a   Cristiano, E ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Brain atrophy; Clinically isolated syndrome; Multiple sclerosis; SIENAX

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICALLY ISOLATED SYNDROME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DATA ANALYSIS; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SYNDROME; WHITE MATTER;

ADULT; ATROPHY; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PROSPECTIVE STUDIES; SYNDROME;

EID: 77957296229     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.04.007     Document Type: Article

References (20)

1. Tintore M., et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. 2006, 67:968-972.
2. Ferguson B., et al. Axonal damage in acute multiple sclerosis lesions. Brain. 1997, 120:393-399.
3. Trapp B.D., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998, 338:278-285.
4. Arnold D.L., et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med. 1990, 14:154-159.
5. De Stefano N., et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol. 1995, 38:901-909.
6. Narayana P.A., et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol. 1998, 43:56-71.
7. Rudick R.A., et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology. 1999, 53:1698-1704.
8. Horakova D., et al. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. J Neurol Sci. 2009, 282:112-119.
9. Dalton C.M., et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain. 2004, 127:1101-1107.
10. Smith S.M., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002, 17:479-489.
11. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001, 20:45-57.
12. De Stefano N., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology. 2003, 60:1157-1162.
13. Simon J.H. Brain atrophy in multiple sclerosis: what we know and would like to know. Mult Scler. 2006, 12:679-687.
14. Kidd D., et al. Cortical lesions in multiple sclerosis. Brain. 1999, 122:17-26.
15. Peterson J.W., et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001, 50:389-400.
16. Evangelou N., et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001, 124:1813-1820.
17. Filippi M., et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain. 2003, 126:433-437.
18. Enzinger C., et al. Accelerated evolution of brain atrophy and " black holes" in MS patients with APOE-epsilon 4. Ann Neurol. 2004, 55:563-569.
19. Simon J.H. From enhancing lesions to brain atrophy in relapsing MS. J Neuroimmunol. 1999, 98:7-15.
20. Coles A.J., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol. 1999, 46:296-304.